Interpretable multimodal radiopathomics model predicting pathological complete response to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma
Baojia Qi, Zhaoyu Jiang, Haixia Shen, Jiacheng Li, Zhixiang Wang, Min Fang, Changchun Wang, Youhua Jiang, Jingping Yuan, Inigo Bermejo, Andre Dekker, Dirk De Ruysscher, Leonard Wee, Wencheng Zhang, Yongling Ji, Zhen Zhang · 2025
Read Interpretable multimodal radiopathomics model predicting pathological complete response to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma by Baojia Qi, Zhaoyu Jiang, Haixia Shen, Jiacheng Li, Zhixiang Wang, Min Fang, Changchun Wang, Youhua Jiang, Jingping Yuan, Inigo Bermejo, Andre Dekker, Dirk De Ruysscher, Leonard Wee, Wencheng Zhang, Yongling Ji, Zhen Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12719895.txt.
Description
Baojia Qi and co-authors built a computer model in 2025 to forecast how throat cancer will respond to drug and immune therapy given before surgery. Their study drew on scans and slide images from 335 patients at three centers. The team trained the model on one group and tested it on two more.
Models that used scan data alone or slide data alone did worse than one that joined both. The joined model also gave reasons for each call, and a screen tool lets doctors explore the results. Such a tool could help teams choose between close watching and prompt surgery for each patient.
Catalog record
| CREATOR | Baojia Qi, Zhaoyu Jiang, Haixia Shen, Jiacheng Li, Zhixiang Wang, Min Fang, Changchun Wang, Youhua Jiang, Jingping Yuan, Inigo Bermejo, Andre Dekker, Dirk De Ruysscher, Leonard Wee, Wencheng Zhang, Yongling Ji, Zhen Zhang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |